Back to Results
First PageMeta Content
Science / Pharmaceutical sciences / Food and Drug Administration / Design of experiments / Pharmacology / Essure / Clinical trial / Adverse event / Clinical research / Pharmaceutical industry / Research


ESS305 Post-Approval Study: 18-month interim report Conc-eptus, December 12, 2008 FDA CDRH DMC
Add to Reading List

Open Document

File Size: 601,07 KB

Share Result on Facebook

City

Mountain View / /

Company

Clinical Study Milestone CONCEPTUS INC. / Study Over-Due CONCEPTUS INC. / Patient Enrollment Complete CONCEPTUS INC. / Conceptus Inc. / June July August September October November CONCEPTUS INC. / Acuna-Narvaez Regulatory Affairs Associate Conceptus Inc. / /

Country

United States / /

Currency

pence / /

/

Event

FDA Phase / /

/

MedicalTreatment

catheter / Hysteroscopy / /

Organization

Food and Drug Administration / FDA CDRH DMC PMA Document Mail Center / Center for Devices / /

Person

Schedule As / Timeline As / Rachelle Acuna-Narvaez / /

/

Position

Investigator / GENERAL INFORMATION Sponsor Information Name / Physician / General / effectiveness ofthe ESS305 physician / /

Product

PAGE1-1 CONFIDENTIAL ESS305 Post-Approval Study / PAGE1-1 / ESS305 / P020014 / /

ProvinceOrState

Maryland / California / /

PublishedMedium

the ESS305 Post / /

Technology

6 Protocol / /

SocialTag